Your browser doesn't support javascript.
loading
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.
Reig, Maria; Forner, Alejandro; Rimola, Jordi; Ferrer-Fàbrega, Joana; Burrel, Marta; Garcia-Criado, Ángeles; Kelley, Robin K; Galle, Peter R; Mazzaferro, Vincenzo; Salem, Riad; Sangro, Bruno; Singal, Amit G; Vogel, Arndt; Fuster, Josep; Ayuso, Carmen; Bruix, Jordi.
Afiliação
  • Reig M; BCLC Group, Liver Unit, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain. Electronic address: mreig1@clinic.cat.
  • Forner A; BCLC Group, Liver Unit, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain.
  • Rimola J; BCLC Group, Radiology Department, CDI, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Ferrer-Fàbrega J; BCLC Group, Surgery Department, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Burrel M; BCLC Group, Vascular Department, CDI, Hospital Clinic of Barcelona, Barcelona University, University of Barcelona, Barcelona, Spain.
  • Garcia-Criado Á; BCLC Group, Radiology Department, CDI, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Kelley RK; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
  • Galle PR; Department of Internal Medicine, Mainz University Medical Center, Mainz, Germany.
  • Mazzaferro V; Department of Oncology, University of Milan and HPB Surgery and Liver Transplantation, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Salem R; Department of Radiology, Section of Interventional Radiology, Northwestern University, Chicago, IL, USA.
  • Sangro B; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain; Liver Unit, Clinica Universidad de Navarra, Pamplona, Spain.
  • Singal AG; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Vogel A; Hannover Medical School, Department of Gastroenterology, Hepatology and Endocrinology, Hannover, Germany.
  • Fuster J; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain; BCLC Group, Surgery Department, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Ayuso C; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain; BCLC Group, Radiology Department, CDI, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Bruix J; BCLC Group, Liver Unit, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain. Electronic address: jbruix@clinic.cat.
J Hepatol ; 76(3): 681-693, 2022 03.
Article em En | MEDLINE | ID: mdl-34801630

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prognóstico / Carcinoma Hepatocelular Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prognóstico / Carcinoma Hepatocelular Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article